Feb 7, 2018 Roth Capital Partners Acts as Co-Manager for Viking Therapeutics, Inc. (VKTX) in its $63.3 Million Follow-On Roth Capital Partners
Feb 6, 2018 Roth Capital Partners Acts as Co-Manager for CymaBay Therapeutics, Inc. (Nasdaq:CBAY) in its $144 Million Follow-On Roth Capital Partners
Feb 2, 2018 Roth Capital Partners Acts as Lead Placement Agent for Q BioMed Inc. (OTCQB: QBIO) in its $5.5 Million Follow-On Roth Capital Partners
Feb 1, 2018 Roth Capital Partners Acts as Financial Advisor to GT Biopharma Inc. (OTCQB: GTBP and Euronext Paris: GTBP.PA) in its $7.1 Million Private Placement Roth Capital Partners
Jan 31, 2018 Roth Capital Partners Acts as Co-Manager for Albireo Pharma, Inc. (ALBO) in its $74.7 Million Follow-On Roth Capital Partners
Jan 30, 2018 Roth Capital Partners Acts as Joint Book-Running Manager for Eyenovia Inc. (EYEN) in its $27.3 Million IPO Roth Capital Partners
Jan 29, 2018 Roth Capital Partners Acts as Co-Manager for Stemline Therapeutics, Inc. (STML), in its $59.6 Million Follow-On Roth Capital Partners
Jan 9, 2018 Roth Capital Partners Acts as Sole Placement Agent for Radisys Corporation (NASDAQ: RSYS) in its $17 Million Senior Notes Financing Roth Capital Partners
Jan 3, 2018 Roth Capital Partners Acts as Sole Book-Running Manager for iClick Interactive Asia Group Limited (NASDAQ:ICLK) in its $34.5 Million IPO Roth Capital Partners